Search

everythinglearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Women with acne have lower levels of a specific hormone marker than women without acne.

Androgens may improve pig reproduction by enhancing ovulation and litter size.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Androgens and estrogens are crucial for insulin secretion in males.

Testosterone undecanoate can reduce the negative effects of Finasteride on male reproductive health.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Postmenopausal hyperandrogenism involves excess male hormones causing symptoms like hair growth and acne, and requires ruling out tumors and other disorders.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

A new method effectively predicts estrogen-related health effects for early screening.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.